أسونديكسيان

In the evolving landscape of cardiovascular medicine, the development of an experimental drug to reduce the risk of recurrent stroke represents a significant potential shift in how we manage secondary prevention for high-risk patients. For those who have already experienced a cerebrovascular event, the primary medical objective is often to mitigate the threat of a … Read more